Hypertension treatment | 合法藥品大搜索

2018年1月7日—Ifthecombinationoftelmisartan80mgdailyandramipril10mgdailyismore...affinitywastelmisartan>olmesartan>candesartan³valsartan³losartan.1...除了ARB，Telmisartan活化PPARγ的效力也與TZD做一比較， ...

最新版WHO/ISH高血壓規範也於2003年出版，自從一九九九年出版WHO/ISH高血壓管理規範後，現在已經有更多證據支持收縮壓140 mmHg的標準足以構成「低危險群」患者的條件。WHO/ISH和ESH/ESC的定義非常類似。

註：高危險群病患

至於其他規範，WHO/ISH 2003的建議是針對心血管高危險群病患，例如糖尿病患者提供較積極的血壓目標。

在 JNC 7中，新規劃了 prehypertension(高血壓前期)，而 stages 2 and 3 HTN 被合併為一級

This slide details the treatment path recommended by the JNC VII guidelines.

As shown, treatment of hypertension begins with implementing lifestyle changes; this is followed by pharmacologic treatment if BP target levels are not reached.

Compelling indications refer to co-morbidities, such as heart failure, post-myocardial infarction, at high risk of coronary disease, diabetes, and chronic kidney disease.

JNC 7 provides new guidelines for prevention and management of hypertension.

The BP goal for individuals without substantial comorbidity is <140/90 mm Hg.

Patients with diabetes or chronic renal failure should aim for a BP <130/80 mm Hg.